Oncostellae SL
Latest round
- Series A
Last raised
- Mar 2024
Total raised
- $1.6M
Investors
- 3
About Oncostellae SL
Founded in 2013 and based in Santiago de Compostela, Spain, Oncostellae SL is a clinical-stage biopharmaceutical company. The company was founded by Julio Castro. Oncostellae develop small-molecule drugs for use as drugs in oncology and inflammatory/automotive diseases. The firm’s pipeline product portfolio includes OST-122, a drug that targets inflammatory bowel disease (IBD); and OST-499, a drug being developed to treat uterine fibroids and other gynecological conditions.
Who invested in Oncostellae SL
3 investors across 2 rounds
See all investors in Oncostellae SL
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Oncostellae SL
Who invested in Oncostellae SL?
Oncostellae SL has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Oncostellae SL raised?
Oncostellae SL has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Oncostellae SL last raise money?
Oncostellae SL's most recent round on record is a Series A, in Mar 2024.
What does Oncostellae SL do?
Founded in 2013 and based in Santiago de Compostela, Spain, Oncostellae SL is a clinical-stage biopharmaceutical company.
Where is Oncostellae SL headquartered?
Oncostellae SL is headquartered in Santiago de Compostela, Spain.
Which VCs invest in companies like Oncostellae SL?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Oncostellae SL's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Oncostellae SL? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.